• SENSEX 76,718.56
    148.21 (+0.19%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
  • Power Fin.Corpn.
    351.60 486.45(%)
  • Netweb Technol.
    5,347.65 5,810.00(%)
  • Antelopus Selan
    1,035.95 951.45(%)
  • IFCI
    101.60 99.45(%)
  • HDFC Bank
    712.75 1,020.35(%)
  • Godrej Consumer
    859.50 891.10(%)
  • Max Healthcare
    988.00 903.50(%)
  • Milky Mist Dairy
    268.75 255.10(%)
  • Solar Industries
    21,569.40 20,760.15(%)
  • Elgi Equipments
    629.30 643.30(%)
  • Energy InfrTrust
    74.25 102.00(%)
  • Ather Energy
    1,630.00 481.25(%)
  • Bharat Dynamics
    1,266.45 1,655.25(%)
  • Jyoti CNC Auto.
    999.00 1,055.00(%)
  • Welspun Corp
    2,675.00 2,593.15(%)
  • Divi's Lab.
    9,277.55 9,296.00(%)
  • Anant Raj
    634.60 744.10(%)
  • Coal India
    428.40 490.90(%)
  • RBL Bank
    409.00 397.95(%)
  • Multi Comm. Exc.
    3,180.35 1,496.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gufic BioSciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2285.0
  • ISIN : INE742B01025
438.80 18 (4.22%)
  • As on 03 Sep 2026 (EOD)

  • Today’s Low

    415.50

  • Today’s High

    453.95

  • Open

    419.75

  • Perv Close

    421.05

  • 52W Low

    268.00

  • 52W High

    453.95

Key Indicators

  • P/E(TTM)

    59.92

  • Mar.Cap (₹Cr.)

    4,400.40

  • Div & Yield %

    0.02

  • Book Value(₹)

    66.23

  • Debt-Equity Ratio

    4.22

  • AGM Date

    02-Sep-2026

  • EPS

    7.33

  • P/E Ratio

    59.92

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    4,400.40

  • RONW (%)

    16.17

  • ROCE (%)

    14.95

Score Board

  • Equity (₹ in Cr.)

    10.03

  • BV (₹)

    66.20

  • Sales( ₹ in Cr.)

    940.48

  • NP (in Cr.)

    63.15

  • NP Var(%)

    -10.0

  • Div%

    10.0

  • CPS (₹)

    9.40

  • EPS (₹)

    6.30

  • Traded Value (₹ in Lakhs)

    4,404.91

  • 52 Week High

    453.95

  • 52 Week Low

    268.00

  • Price BSE

    439.0

  • Price NSE

    439.00

  • Market Capital( in Cr.)

    4,404.91

  • P/C Ratio

    46.80

  • P/E Ratio

    69.70

  • Price Vs.BV

    6.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 940.48 819.81 806.67 690.62 779.16 487.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 940.48 819.81 806.67 690.62 779.16 487.70
Other Income 2.58 3.62 2.18 2.57 3.10 3.73
Stock Adjustments 68.95 24.91 -0.57 33.39 19.39 -14.29
Total Income 1,012.01 848.34 808.28 726.58 801.65 477.14
EXPENDITURE :            
Raw Materials 490.15 399.62 389.32 365.21 431.35 236.00
Power and Fuel Cost 32.34 18.46 17.61 15.24 11.00 9.94
Employee Cost 151.68 127.19 109.67 86.73 85.61 66.22
Other Manufacturing Expenses 45.53 29.25 28.43 24.67 27.42 18.20
Selling and Administration Expenses 129.36 121.79 105.28 87.63 77.97 45.93
Miscellaneous Expenses 10.02 12.03 8.48 9.88 17.16 13.20
Employee Benefit Expenses 151.68 127.19 109.67 86.73 85.61 66.22
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 859.08 708.33 658.79 589.36 650.51 389.49
Operating Profit 152.93 140.01 149.48 137.22 151.14 87.65
Interest 36.61 24.52 16.79 8.22 5.37 13.63
Gross Profit 116.32 115.49 132.69 129.00 145.77 74.02
Depreciation 30.83 21.06 17.02 22.28 18.93 16.31
Profit Before Tax 85.49 94.43 115.67 106.72 126.84 57.71
Current Tax 13.70 18.74 26.37 28.21 32.15 17.20
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 8.63 5.75 3.17 -1.19 -1.15 -3.72
Reported Net Profit 63.15 69.93 86.14 79.70 95.84 44.23
Extraordinary Items 0.00 0.15 -1.67 0.02 0.05 0.02
Adjusted Net Profit 63.15 69.78 87.81 79.68 95.79 44.21
Adjustment below Net Profit 0.10 -0.10 0.00 0.00 0.00 0.26
P & L Balance brought forward 421.28 352.46 267.29 188.55 93.68 49.58
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.00 1.00 0.97 0.97 0.97 0.39
P & L Balance carried down 483.53 421.28 352.46 267.29 188.55 93.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 10.00 10.00
Dividend Per Share(Rs) 0.10 0.10 0.10 0.10 0.10 0.10
Earnings Per Share-Unit Curr 6.30 6.97 8.59 8.22 9.89 4.56
Earnings Per Share(Adj)-Unit Curr 6.30 6.97 8.59 8.22 9.89 4.56
Book Value 66.23 59.96 53.11 35.88 27.76 17.89
Book Value(Adj)-Unit Curr 66.23 59.96 53.11 35.88 27.76 17.89

Shareholding Pattern

  • Promoter Group

    72.50%

  • Public Share Holding

    27.50%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 30,714,853 30.63 30,714,853 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,993,298 41.88 41,993,298 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 72,708,151 72.50 72,708,151 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 464,753 0.46 464,753 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,443,537 3.43 3,443,537 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 243,267 0.24 243,267 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,151,557 4.14 4,151,557 33
2] Non Institution
Bodies Corporate 2,317,138 2.31 2,317,138 160
Clearing Members 3,375,620 3.37 3,375,620 14
Directors of their Relatives 562,045 0.56 562,045 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 469,183 0.47 469,183 650
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,670,337 1.67 1,670,337 588
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,595,163 2.59 2,595,163 3
Individuals holding nominal share capital up to Rs. 1 lakh 11,439,457 11.41 11,414,457 28,275
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 258,886 0.26 258,886 2
Sub Total 23,422,798 23.36 23,397,798 29,715
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 100,282,506 100.00 100,257,506 29,753

Company Background

Gufic BioSciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Gufic BioSciences Ltd
  • BSE Code : 2285.0
  • ISIN : INE742B01025

  • Incorporation Year

    1984

  • Registered Office

    Shop-37 1st Flr Kamala Bhavan
    Swami Nityanand Road Andheri(E, Mumbai,
    Maharashtra-400069

  • Telephone

    91-022-66919187/67261007/66919189

  • FAX

    91-022-26118103/26169008

  • Chairman

    Jayesh P Choksi

  • Managing Director

  • Company Secretary

    Ami Naresh Shah

  • Auditor

    Mittal Agarwal & Company

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gufic BioSciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gufic BioScience 439.25 943.06 940.48 59.92 11.90
Abbott India 26,025.15 7,217.19 6,929.05 34.25 43.78
Astrazeneca Phar 6,870.25 2,304.07 2,275.58 101.26 27.86
Glaxosmi. Pharma 2,946.60 3,932.76 3,790.20 47.07 58.17
Novartis India 1,602.15 398.23 356.27 40.46 16.64
Cipla 1,413.15 20,102.60 18,979.95 37.14 13.88
Bliss GVS Pharma 649.00 773.53 729.81 60.26 12.51
Fermenta Biotec. 522.75 474.15 450.25 24.40 18.77
Amrutanjan Healt 501.90 520.13 502.55 26.88 24.16
Guj. Themis Bio. 412.60 152.47 150.80 110.32 27.21
Ambalal Sarabhai 44.79 19.52 3.94 82.94 6.77